Grimaldi-Bensouda, Lamiae http://orcid.org/0000-0003-1952-5467
Papeix, Caroline
Hamon, Yann
Benichou, Jacques
Abenhaim, Lucien
Funding for this research was provided by:
Centre for Risk Research Inc. Montreal (Research Credit Tax)
Article History
Received: 7 March 2023
Revised: 10 June 2023
Accepted: 13 June 2023
First Online: 23 June 2023
Declarations
:
: LG-B was the recipient of a research fellowship from INSERM (French National Institute of Health and Medical Research) at the time of the study and was employed by LA-SER, the company conducting the study. CP is a member of the board for Bayer Schering Pharma, Novartis, Roche, Teva Pharmaceutical Industries Ltd and Sanofi-Genzyme Bio Ventures; she has also received payment for lectures and participation in speakers’ bureaus from Bayer Schering Pharma, Novartis, Teva Pharmaceutical Industries Ltd, Merck Serono SA, Biogen Idec and Genzyme. YH was employed by LA-SER, the company conducting the study. JB was a consultant for LA-SER. LA was a stock-holder and chairman of LA-SER and Centre for Risk Research Inc., an independent research organisation that owns and develops the PGRx database. LA-SER and Centre for Risk Research Inc. have no commercial interests in any of the products investigated in this study.
: All steps performed in our study (data collection and interviews) were in accordance with the ethical standards of the national research committee, with the 1964 Helsinki declaration and its later amendments and with the national data protection office requirements.